Dupont De Nemours Inc's stock rose by 3.02% during regular trading, reaching a 52-week high. This positive movement aligns with broader market strength, as the Nasdaq-100 rose 0.58% and the S&P 500 gained 0.39%.
The stock's increase is attributed to the overall favorable market conditions, indicating a sector rotation as investors show renewed interest in industrial stocks. The strong performance of the broader market has provided a supportive backdrop for Dupont's gains, reflecting investor confidence in the company's future prospects.
As Dupont De Nemours Inc continues to perform well, this upward trend may attract further investment, potentially leading to additional growth opportunities. Investors will be watching closely for any upcoming developments that could influence the stock's trajectory.
Wall Street analysts forecast DD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DD is 48.27 USD with a low forecast of 44.00 USD and a high forecast of 51.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
Wall Street analysts forecast DD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DD is 48.27 USD with a low forecast of 44.00 USD and a high forecast of 51.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
2 Hold
0 Sell
Strong Buy
Current: 44.630
Low
44.00
Averages
48.27
High
51.00
Current: 44.630
Low
44.00
Averages
48.27
High
51.00
Deutsche Bank
David Begleiter
Buy
maintain
$46
2026-01-23
Reason
Deutsche Bank
David Begleiter
Price Target
$46
AI Analysis
2026-01-23
maintain
Buy
Reason
Deutsche Bank analyst David Begleiter placed a "Catalyst Call: Buy" on DuPont as a short-term investment idea. The firm keeps a Buy rating on the name with a $46 price target. The reporting of DuPont's first quarter following the spinoff of its electronics business "will highlight a new era of stability, simplicity and clarity," the analyst tells investors in a research note. Deutsche says the stock shares trade at a 34% discount to its sum-of-the-parts.
RBC Capital
Outperform
maintain
$48 -> $51
2026-01-21
Reason
RBC Capital
Price Target
$48 -> $51
2026-01-21
maintain
Outperform
Reason
RBC Capital raised the firm's price target on DuPont to $51 from $48 and keeps an Outperform rating on the shares as part of a broader research note previewing Q4 for Specialty Chemicals. The firm is expecting in-line prints for Q4 and continues to see company-specific items driving improvement in 2026, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DD
Unlock Now
Citi
Patrick Cunningham
Buy
maintain
$47 -> $50
2026-01-21
Reason
Citi
Patrick Cunningham
Price Target
$47 -> $50
2026-01-21
maintain
Buy
Reason
Citi analyst Patrick Cunningham raised the firm's price target on DuPont to $50 from $47 and keeps a Buy rating on the shares. The firm adjusted targets in the specialty chemicals group as part of a Q4 preview. Citi sees a better currency and sales environment for the sector, but with the potential for "fresh tariff risks."
JPMorgan
NULL -> Overweight
maintain
$48 -> $50
2026-01-16
Reason
JPMorgan
Price Target
$48 -> $50
2026-01-16
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on DuPont to $50 from $48 and keeps an Overweight rating on the shares. The firm adjusted ratings and targets in the electrical equipment and multi-industry group as part of its Q4 earnings preview. JPMorgan is more positive on "growth related names into and out of the quarter."
About DD
DuPont de Nemours, Inc. is engaged in providing advanced solutions that help transform industries. The Company serves various markets, including healthcare, water, construction, and transportation. The Company’s IndustrialsCo segment is a provider of engineered products and integrated solutions primarily serving medical, including packaging and specialty medical devices, water filtration, worker safety, automotive, including electric vehicles, aerospace and building product end markets. The IndustrialsCo segment offers medical packaging, medical silicones, specialty medical devices, water purification and separation, water filtration and purification resins, flexible packaging products, nonwovens, aramids, construction materials, auto adhesives and fluids.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
